E. Angeloudi

Recent advances in hypertension genomics and RNA interference-based therapeutics: the key to future management?

INTRODUCTION Hypertension is a major contributor to cardiovascular morbidity and mortality. Given the suboptimal control rates with conventional antihypertensive medication, novel approaches are warranted. In the era of precision medicine, integrating hypertension genomics into diagnostic and therapeutic approaches may...